Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Yang Wei0
Samuel Davis0
Jesper Gromada0
Haruka Okamoto0
Andrew J. Murphy0
Date of Patent
September 17, 2024
0Patent Application Number
184574820
Date Filed
August 29, 2023
0Patent Citations
Patent Primary Examiner
Patent abstract
The present invention provides modified glucagon-like peptide 1 (GLP1) polypeptides, fusion proteins comprising modified GLP1 polypeptides, and methods of use thereof. In various embodiments of the invention, the fusion proteins are GLP1 receptor agonists that comprise a modified GLP1 fused to a stabilizing domain. In some embodiments, the fusion proteins comprising modified GLP1 are useful for treating or ameliorating a symptom or indication of a disorder such as obesity and diabetes.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
